The sGC stimulator BAY 41-8543 in a rat model of hypertension-induced heart failure

被引：0
|
作者：
N Haase
N Wilck
L Marko
A Balogh
A Heuser
D Brockschnieder
A Kretschmer
J P Stasch
N Müller
R Dechend
机构：
[1] Max-Delbrueck Ctr. & Medical Faculty of Charite,Experimental and Clinical Research Ctr.
[2] Max-Delbrueck Ctr.,undefined
[3] Bayer HealthCare,undefined
[4] Global Drug Discovery,undefined
[5] Helios Klinik,undefined
来源：
BMC Pharmacology and Toxicology | / 16卷 / Suppl 1期
关键词：
Total Peripheral Resistance; Angiotensinogen; Hemodynamic Monitoring; Diastolic Heart Failure; Pressure Volume Relationship;
D O I：
10.1186/2050-6511-16-S1-A57
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] The sGC stimulator BAY 41-8543 totally reverse hypoxia induced pulmonary hypertension
    Hedelin, P.
    Kylhammar, D.
    Radegran, G.
    EUROPEAN HEART JOURNAL, 2010, 31 : 761 - 761
  • [2] sGC stimulator (BAY 41-8543) for the treatment of heart failure with reduced ejection fraction (HFrEF) and cardio-renal syndrome
    Gawrys, Olga
    Huskova, Zuzana
    Skaroupkova, Petra
    Honetschlagerova, Zuzana
    Vanourkova, Zdenka
    Kikerlova, Sona
    Melenovsky, Vojtech
    Cervenka, Ludek
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21
  • [3] sGC stimulator (BAY 41-8543) for the treatment of heart failure with reduced ejection fraction (HFrEF) and cardio-renal syndrome
    Gawrys, Olga
    Huskova, Zuzana
    Skaroupkova, Petra
    Honetschlagerova, Zuzana
    Vanourkova, Zdenka
    Kikerlova, Sona
    Melenovsky, Vojtech
    Cervenka, Ludek
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (SUPPL 1)
  • [4] Effects of the soluble guanylate cyclase (sGC) stimulator BAY 41-8543 on myocardial function in healthy pigs
    Schwarzl, M.
    Alogna, A.
    Zirngast, B.
    Steendijk, P.
    Maechler, H.
    Pieske, B. M.
    Post, H.
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S48 - S48
  • [5] The soluble guanylate cyclase (sGC) stimulator BAY 41-8543 exerts a negative inotropic effect in healthy pigs
    Schwarzl, M.
    Alogna, A.
    Zirngast, B.
    Steendijk, P.
    Maechler, H.
    Pieske, B. M.
    Post, H.
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 108 - 108
  • [6] Inhalative application of soluble guanylyl cyclase stimulator BAY 41-8543 for treatement of pulmonary arterial hypertension
    Egemnazarov, B.
    Amirjanians, V.
    Kojonazarov, B.
    Sydykov, A.
    Stasch, J. -P.
    Weissmann, N.
    Grimminger, F.
    Seeger, W.
    Schermuly, R. T.
    Ghofrani, H. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [7] SGC STIMULATOR, BAY41 8543, FOR THE TREATMENT OF HEART FAILURE WITH REDUCED EJECTION FRACTION AND CARDIORENAL SYNDROME.
    Gawrys, Olga
    Skaroupkova, Petra
    Huskova, Zuzana
    Honetschlagerova, Zuzana
    Vanourkova, Zdenka
    Kikerlova, Sona
    Melenovsky, Vojtech
    Cervenka, Ludek
    JOURNAL OF HYPERTENSION, 2023, 41 : E356 - E356
  • [8] Chronic intratracheal application of the soluble guanylyl cyclase stimulator BAY 41-8543 ameliorates experimental pulmonary hypertension
    Amirjanians, Matthieu
    Egemnazarov, Bakytbek
    Sydykov, Akylbek
    Kojonazarov, Baktybek
    Brandes, Ralf
    Luitel, Himal
    Pradhan, Kabita
    Stasch, Johannes-Peter
    Redlich, Gorden
    Weissmann, Norbert
    Grimminger, Friedrich
    Seeger, Werner
    Ghofrani, Hossein
    Schermuly, Ralph
    ONCOTARGET, 2017, 8 (18) : 29613 - 29624
  • [9] Soluble guanylate cyclase stimulator BAY 41-8543 and female sex ameliorate uremic aortic remodeling in a rat model of mild uremia
    Stancu, Bianca
    Kraemer, Stephanie
    Loof, Tanja
    Mika, Alice
    Amann, Kerstin
    Neumayer, Hans-H.
    Peters, Harm
    JOURNAL OF HYPERTENSION, 2015, 33 (09) : 1907 - 1921
  • [10] Cardiovascular actions of a novel NO-independent guanylyl cyclase stimulator, BAY 41-8543:: in vivo studies
    Stasch, JP
    Dembowsky, K
    Perzborn, E
    Stahl, E
    Schramm, M
    BRITISH JOURNAL OF PHARMACOLOGY, 2002, 135 (02) : 344 - 355
12345